- Home
- IFBD vs APM Comparison
IFBD vs APM Comparison
Compare IFBD & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFBD
- APM
- Stock Information
- Founded
- IFBD 2001
- APM 2010
- Country
- IFBD China
- APM United Kingdom
- Employees
- IFBD N/A
- APM N/A
- Industry
- IFBD Computer Software: Prepackaged Software
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- IFBD Technology
- APM Health Care
- Exchange
- IFBD Nasdaq
- APM Nasdaq
- Market Cap
- IFBD 8.4M
- APM 6.9M
- IPO Year
- IFBD 2021
- APM 2018
- Fundamental
- Price
- IFBD $1.04
- APM $2.64
- Analyst Decision
- IFBD
- APM
- Analyst Count
- IFBD 0
- APM 0
- Target Price
- IFBD N/A
- APM N/A
- AVG Volume (30 Days)
- IFBD 8.4K
- APM 20.0M
- Earning Date
- IFBD 01-01-0001
- APM 04-30-2025
- Dividend Yield
- IFBD N/A
- APM N/A
- EPS Growth
- IFBD N/A
- APM N/A
- EPS
- IFBD N/A
- APM N/A
- Revenue
- IFBD $1,437,848.00
- APM N/A
- Revenue This Year
- IFBD N/A
- APM N/A
- Revenue Next Year
- IFBD N/A
- APM N/A
- P/E Ratio
- IFBD N/A
- APM N/A
- Revenue Growth
- IFBD 413.52
- APM N/A
- 52 Week Low
- IFBD $0.89
- APM $0.46
- 52 Week High
- IFBD $3.32
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- IFBD 55.12
- APM 59.96
- Support Level
- IFBD $0.97
- APM $1.26
- Resistance Level
- IFBD $1.04
- APM $4.47
- Average True Range (ATR)
- IFBD 0.04
- APM 0.26
- MACD
- IFBD 0.00
- APM 0.17
- Stochastic Oscillator
- IFBD 72.75
- APM 43.87
About IFBD Infobird Co. Ltd
Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.